Integrative multi-omics reveals CUL4B as a modulator of macrophage pyroptosis and innate defense against Staphylococcus aureus.

Deletion of CUL4B enhances macrophage killing of Staphylococcus aureus and reduces inflammation in mice, indicating CUL4B as a key modulator of innate immune responses.

• Why it matters: Understanding how macrophages respond to Staphylococcus aureus is crucial because the pathogen employs diverse immune evasion strategies and antibiotic resistance complicates treatment, highlighting the need for host-directed therapies.
• What they did: Using multi-omics and systems-level analytics, the study identified CUL4B as a host factor; CRISPR deletion in human macrophages increased bacterial killing and decreased inflammasome activation, while in mice, CUL4B deficiency improved bacterial clearance and reduced tissue damage.
• The result: These findings suggest that targeting CUL4B could modulate macrophage inflammatory responses and improve outcomes against methicillin-resistant Staphylococcus aureus infections.